Literature DB >> 29787394

New developments in the genetic diagnosis of short stature.

Youn Hee Jee1, Jeffrey Baron1, Ola Nilsson2,3.   

Abstract

PURPOSE OF REVIEW: Genome-wide approaches including genome-wide association studies as well as exome and genome sequencing represent powerful new approaches that have improved our ability to identify genetic causes of human disorders. The purpose of this review is to describe recent advances in the genetic causes of short stature. RECENT
FINDINGS: In addition to SHOX deficiency which is one of the most common causes of isolated short stature, PAPPA2, ACAN, NPPC, NPR2, PTPN11 (and other rasopathies), FBN1, IHH and BMP2 have been identified in isolated growth disorders with or without other mild skeletal findings. In addition, novel genetic causes of syndromic short stature have been discovered, including pathogenic variants in BRCA1, DONSON, AMMECR1, NFIX, SLC25A24, and FN1.
SUMMARY: Isolated growth disorders are often monogenic. Specific genetic causes typically have specific biochemical and/or phenotype characteristics which are diagnostically helpful. Identification of additional subjects with a specific genetic cause of short stature often leads to a broadening of the known clinical spectrum for that condition. The identification of novel genetic causes of short stature has provided important insights into the underlying molecular mechanisms of growth failure.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29787394      PMCID: PMC7241654          DOI: 10.1097/MOP.0000000000000653

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  46 in total

1.  BMP signaling stimulates cellular differentiation at multiple steps during cartilage development.

Authors:  Tatsuya Kobayashi; Karen M Lyons; Andrew P McMahon; Henry M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-01       Impact factor: 11.205

2.  Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.

Authors:  Audrey De Rocca Serra-Nédélec; Thomas Edouard; Karine Tréguer; Mylène Tajan; Toshiyuki Araki; Marie Dance; Marianne Mus; Alexandra Montagner; Maïté Tauber; Jean-Pierre Salles; Philippe Valet; Benjamin G Neel; Patrick Raynal; Armelle Yart
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

3.  Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis.

Authors:  Malene R Jepsen; Søren Kløverpris; Jakob H Mikkelsen; Josefine H Pedersen; Ernst-Martin Füchtbauer; Lisbeth S Laursen; Claus Oxvig
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

4.  A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans.

Authors:  Eva-Lena Stattin; Fredrik Wiklund; Karin Lindblom; Patrik Onnerfjord; Björn-Anders Jonsson; Yelverton Tegner; Takako Sasaki; André Struglics; Stefan Lohmander; Niklas Dahl; Dick Heinegård; Anders Aspberg
Journal:  Am J Hum Genet       Date:  2010-02-04       Impact factor: 11.025

5.  IHH Gene Mutations Causing Short Stature With Nonspecific Skeletal Abnormalities and Response to Growth Hormone Therapy.

Authors:  Gabriela A Vasques; Mariana F A Funari; Frederico M Ferreira; Miriam Aza-Carmona; Lucia Sentchordi-Montané; Jimena Barraza-García; Antonio M Lerario; Guilherme L Yamamoto; Michel S Naslavsky; Yeda A O Duarte; Debora R Bertola; Karen E Heath; Alexander A L Jorge
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

6.  Inactivation of AMMECR1 is associated with growth, bone, and heart alterations.

Authors:  Mariana Moysés-Oliveira; Giuliana Giannuzzi; Richard J Fish; Jill A Rosenfeld; Florence Petit; Maria de Fatima Soares; Leslie Domenici Kulikowski; Adriana Di-Battista; Malú Zamariolli; Fan Xia; Thomas Liehr; Nadezda Kosyakova; Gianna Carvalheira; Michael Parker; Eleanor G Seaby; Sarah Ennis; Rodney D Gilbert; R Tanner Hagelstrom; Maria L Cremona; Wenhui L Li; Alka Malhotra; Anjana Chandrasekhar; Denise L Perry; Ryan J Taft; Julie McCarrier; Donald G Basel; Joris Andrieux; Taiza Stumpp; Fernanda Antunes; Gustavo José Pereira; Marguerite Neerman-Arbez; Vera Ayres Meloni; Margaret Drummond-Borg; Maria Isabel Melaragno; Alexandre Reymond
Journal:  Hum Mutat       Date:  2017-12-14       Impact factor: 4.878

7.  De Novo Mutations in SLC25A24 Cause a Craniosynostosis Syndrome with Hypertrichosis, Progeroid Appearance, and Mitochondrial Dysfunction.

Authors:  Nadja Ehmke; Luitgard Graul-Neumann; Lukasz Smorag; Rainer Koenig; Lara Segebrecht; Pilar Magoulas; Fernando Scaglia; Esra Kilic; Anna F Hennig; Nicolai Adolphs; Namrata Saha; Beatrix Fauler; Vera M Kalscheuer; Friederike Hennig; Janine Altmüller; Christian Netzer; Holger Thiele; Peter Nürnberg; Gökhan Yigit; Marten Jäger; Jochen Hecht; Ulrike Krüger; Thorsten Mielke; Peter M Krawitz; Denise Horn; Markus Schuelke; Stefan Mundlos; Carlos A Bacino; Penelope E Bonnen; Bernd Wollnik; Björn Fischer-Zirnsak; Uwe Kornak
Journal:  Am J Hum Genet       Date:  2017-11-02       Impact factor: 11.025

8.  Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations.

Authors:  Alexandra Gkourogianni; Melissa Andrew; Leah Tyzinski; Melissa Crocker; Jessica Douglas; Nancy Dunbar; Jan Fairchild; Mariana F A Funari; Karen E Heath; Alexander A L Jorge; Tracey Kurtzman; Stephen LaFranchi; Seema Lalani; Jan Lebl; Yuezhen Lin; Evan Los; Dorothee Newbern; Catherine Nowak; Micah Olson; Jadranka Popovic; Štepánka Pruhová; Lenka Elblova; Jose Bernardo Quintos; Emma Segerlund; Lucia Sentchordi; Marwan Shinawi; Eva-Lena Stattin; Jonathan Swartz; Ariadna González Del Angel; Sinhué Diaz Cuéllar; Hidekazu Hosono; Pedro A Sanchez-Lara; Vivian Hwa; Jeffrey Baron; Ola Nilsson; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

9.  Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature.

Authors:  Nadine N Hauer; Heinrich Sticht; Sangamitra Boppudi; Christian Büttner; Cornelia Kraus; Udo Trautmann; Martin Zenker; Christiane Zweier; Antje Wiesener; Rami Abou Jamra; Dagmar Wieczorek; Jaqueline Kelkel; Anna-Maria Jung; Steffen Uebe; Arif B Ekici; Tilman Rohrer; André Reis; Helmuth-Günther Dörr; Christian T Thiel
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

10.  Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor.

Authors:  Jerid W Robinson; Giulia Vigone; Leia C Shuhaibar; Ninna P Shuhaibar; Jeremy R Egbert; Valentina Baena; Tracy F Uliasz; Deborah Kaback; Siu-Pok Yee; Robert Feil; Melanie C Fisher; Caroline N Dealy; Lincoln R Potter; Laurinda A Jaffe
Journal:  Elife       Date:  2017-12-04       Impact factor: 8.140

View more
  11 in total

Review 1.  Growth plate gene involment and isolated short stature.

Authors:  Maria Felicia Faienza; Mariangela Chiarito; Giacomina Brunetti; Gabriele D'Amato
Journal:  Endocrine       Date:  2020-06-05       Impact factor: 3.633

2.  Focused Revision: ACMG practice resource: Genetic evaluation of short stature.

Authors:  Cassie S Mintz; Laurie H Seaver; Mira Irons; Adda Grimberg; Reymundo Lozano
Journal:  Genet Med       Date:  2021-01-29       Impact factor: 8.822

Review 3.  Genetic evaluation in children with short stature.

Authors:  Elaine Zhou; Benjamin Roland Hauser; Youn Hee Jee
Journal:  Curr Opin Pediatr       Date:  2021-08-01       Impact factor: 2.893

4.  Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours.

Authors:  Samantha M Mirczuk; Christopher J Scudder; Jordan E Read; Victoria J Crossley; Jacob T Regan; Karen M Richardson; Bigboy Simbi; Craig A McArdle; David B Church; Joseph Fenn; Patrick J Kenny; Holger A Volk; Caroline P Wheeler-Jones; Márta Korbonits; Stijn J Niessen; Imelda M McGonnell; Robert C Fowkes
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

5.  Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH.

Authors:  Meiping Chen; Hui Miao; Hanting Liang; Xiaoan Ke; Hongbo Yang; Fengying Gong; Linjie Wang; Lian Duan; Shi Chen; Hui Pan; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-16       Impact factor: 6.055

6.  Molecular genetic analysis and growth hormone response in patients with syndromic short stature.

Authors:  Huihui Sun; Na Li; Naijun Wan
Journal:  BMC Med Genomics       Date:  2021-11-05       Impact factor: 3.063

7.  Heterozygous NPR2 Variants in Idiopathic Short Stature.

Authors:  Lana Stavber; Maria Joao Gaia; Tinka Hovnik; Barbara Jenko Bizjan; Maruša Debeljak; Jernej Kovač; Jasna Šuput Omladič; Tadej Battelino; Primož Kotnik; Klemen Dovč
Journal:  Genes (Basel)       Date:  2022-06-15       Impact factor: 4.141

8.  Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.

Authors:  Javier-Fernando Montero-Bullón; Óscar González-Velasco; María Isidoro-García; Jesus Lacal
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

9.  Genetic Regulation of Adult Stature in Humans.

Authors:  Allen W Root
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 10.  Emotional Deprivation in Children: Growth Faltering and Reversible Hypopituitarism.

Authors:  Alan David Rogol
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.